Immune Checkpoint Inhibitor

Immune Checkpoint Inhibitor

Oncology

Non Small cell tumors shown on orientation image in upper left. Tumor cells shown with inactive T cells. Nivolumab monoclonal anti-PD-1 antibodies causing the activation of the T cells. The activated T cells are then shown attacking the pituitary causing hypophysitis.

‚Äć

Back to Portfolio >